Table 1 showing results with presenting symptoms, stage of disease, management and outcome.
From: Squamous cell carcinoma of the tonsillar remnant - clinical presentation and oncological outcome
|
Age at diagnosis (years) | Gender |
Presenting symptoms |
TNM stage | Management |
Follow-up (months) | Outcome |
|---|---|---|---|---|---|---|
| 43 | M |
Neck Mass Unknown 1° | T1N3M0 |
Excision Biopsy RND Radiotherapy | 120 | Alive |
| 67 | F | Neck Mass | T3N3M1 | Palliative care | 2 | Deceased |
| 57 | M |
Sore throat Neck Mass | T4N2cM0 |
KTP Bilateral MRND (type I+II) Radiotherapy Cisplatin Chemotherapy |
Lost after 12 | Alive |
| 56 | F |
Neck Mass Unknown 1° | TisN2aM0 |
KTP MRND (type I) Radiotherapy | 72 | Alive |
| 74 | M |
Neck Mass Unknown 1° | T1N1M0 | Radiotherapy | 84 | Alive |
| 47 | M |
Neck Mass Tonsil Mass | T3N3M0 |
KTP MRND (type I) Radiotherapy | 60 | Alive |
| 67 | F | Sore throat | T2N0M0 |
Excision Biopsy Radiotherapy | 60 | Alive |
| 56 | M |
Neck Mass Unknown 1° | T1N2bM0 |
MRND Radiotherapy Cisplatin Chemotherapy | 68 | Alive |
| 50 | M |
Neck Mass Unknown 1° | T2N2aM0 |
MRND Radiotherapy Cisplatin Chemotherapy | 48 | Alive |
| 64 | M |
Sore throat Neck Mass | T2N3M0 |
Radiotherapy Cisplatin Chemotherapy Staged MRND | 24 | Alive |